Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2023

Feb 11, 2023

31971_dirs_2023-02-10_7789d4cc-2404-4e35-be52-7358566b27fc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2022-12-31

Reporting Person: Lalomia Brent (Vice President QA and RA)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-10-03 Common Stock L 1.32 $81.629 Acquired 680.057 Direct